ClinicalTrials.Veeva

Menu
H

Health Initiatives Research, PLLC | Fayetteville, AR

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

AVP-786
Gantenerumab
LY3002813
Donanemab
Aducanumab
Crenezumab
AGN-241751

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 9 total trials

A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)

The reason for this study is to see how safe and effective the study drug donanemab is in participants with early Alzheimer's disease.Additional part...

Active, not recruiting
Alzheimer Disease
Drug: Donanemab
Drug: Placebo

This is an extension study of the Phase 3 Studies 15-AVP-786-301, 15-AVP-786-302, and 17-AVP-786-305, which also allows participants from the Phase 2...

Active, not recruiting
Agitation in Patients With Dementia of the Alzheimer's Type
Drug: AVP-786

Trial sponsors

Roche logo
Otsuka logo
Biogen logo
G
Lilly logo
US Department of Veterans Affairs (VA) logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems